SMMT SUMMIT THERAPEUTICS INC
2026Q1 · CUSIP 86627T108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
223
Δ holders QoQ
+14
Breadth percentile
Top 22%
Whale holders
104
Δ whales
-5
Inst. holding value
$2.3B
New positions
59
Closed positions
45
Price momentum (1Q)
+2.2%
Put / Call
7/11
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q2 | Top 12% | -31.4% | -39.6% |
| 2024Q4 | Top 14% | +13.9% | +20.3% |
| 2024Q3 | Top 5% | +16.5% | +35.8% |
| 2024Q2 | Top 15% | +67.7% | +86.2% |
| 2023Q1 | Top 5% | — | — |
| 2021Q2 | Top 16% | — | — |
Options Sentiment
Put holders
7
QoQ: -1
Call holders
11
QoQ: +4
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.59
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)